Skip Navigation

Publication Detail

Title: Systems biology and birth defects prevention: blockade of the glucocorticoid receptor prevents arsenic-induced birth defects.

Authors: Ahir, Bhavesh K; Sanders, Alison P; Rager, Julia E; Fry, Rebecca C

Published In Environ Health Perspect, (2013 Mar)

Abstract: The biological mechanisms by which environmental metals are associated with birth defects are largely unknown. Systems biology-based approaches may help to identify key pathways that mediate metal-induced birth defects as well as potential targets for prevention.First, we applied a novel computational approach to identify a prioritized biological pathway that associates metals with birth defects. Second, in a laboratory setting, we sought to determine whether inhibition of the identified pathway prevents developmental defects.Seven environmental metals were selected for inclusion in the computational analysis: arsenic, cadmium, chromium, lead, mercury, nickel, and selenium. We used an in silico strategy to predict genes and pathways associated with both metal exposure and developmental defects. The most significant pathway was identified and tested using an in ovo whole chick embryo culture assay. We further evaluated the role of the pathway as a mediator of metal-induced toxicity using the in vitro midbrain micromass culture assay.The glucocorticoid receptor pathway was computationally predicted to be a key mediator of multiple metal-induced birth defects. In the chick embryo model, structural malformations induced by inorganic arsenic (iAs) were prevented when signaling of the glucocorticoid receptor pathway was inhibited. Further, glucocorticoid receptor inhibition demonstrated partial to complete protection from both iAs- and cadmium-induced neurodevelopmental toxicity in vitro.Our findings highlight a novel approach to computationally identify a targeted biological pathway for examining birth defects prevention.

PubMed ID: 23458687 Exiting the NIEHS site

MeSH Terms: Animals; Arsenic/toxicity*; Chick Embryo; Congenital Abnormalities/etiology; Congenital Abnormalities/prevention & control*; Receptors, Glucocorticoid/antagonists & inhibitors*; Reverse Transcriptase Polymerase Chain Reaction; Systems Biology*; Teratogens/toxicity*

Back
to Top